Metabolomics and Metabolic Reprogramming in Kidney Cancer.

about

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway Hyperpolarized C magnetic resonance imaging, using metabolic imaging to improve the detection and management of prostate, bladder, and kidney urologic malignancies

P2860

Q57069985-92F8AAE6-E98A-4B4D-8FA5-2DB5868F76EF Q59130949-7CB1AAB2-A2E0-4389-B31B-30F58197188C

P2860

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

Item

http://www.wikidata.org/entity/Q52618376

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@en

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@nl

type

Item

label

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@en

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@nl

prefLabel

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@en

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@nl

P1476

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

@en

P2093

Robert H Weiss

http://www.w3.org/2001/XMLSchema#string

P2860

Pathway analysis of kidney cancer using proteomics and metabolic profiling

Hallmarks of Cancer: The Next Generation

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

Argininosuccinate synthase: at the center of arginine metabolism

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

Arginine deprivation therapy for malignant melanoma

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

Novel drugs that target the metabolic reprogramming in renal cell cancer

Urine metabolomics for kidney cancer detection and biomarker discovery

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

P304

175-182

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SEMNEPHROL.2018.01.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29602399

http://www.w3.org/2001/XMLSchema#string

P932

6009840

http://www.w3.org/2001/XMLSchema#string

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

about

P2860

P2860

Metabolomics and Metabolic Reprogramming in Kidney Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932